Literature DB >> 23600875

Interferons lambda, new cytokines with antiviral activity.

K Lopušná1, I Režuchová, T Betáková, L Skovranová, J Tomašková, L Lukáčiková, P Kabát.   

Abstract

Interferons (IFNs) are key cytokines in the establishment of a multifaceted antiviral response. Three distinct types of IFNs are now recognized (type I, type II, and type III) based on their receptor usage, structural features and biological activities. Although all IFNs are important mediators of antiviral protection, their roles in antiviral defence vary. Interferon lambda (IFN-λ) is a recently discovered group of small helical cytokines capable of inducing an antiviral response both in vitro as well as in vivo. They were discovered independently in 2003 by the groups of Sheppard and Kotenko. This family consists of three structurally related IFN-λ subtypes called IFN-λ1 (IL-29), IFN-λ2 (IL-28A), and IFN-λ3 (IL-28B). In this study we investigate the antiviral activities of IFN-λ1, λ2, and λ3 on some medically important viruses, influenza viruses, herpes viruses and lymphocytic choriomeningitis virus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600875     DOI: 10.4149/av_2013_02_171

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  16 in total

1.  Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.

Authors:  Lianghua Bin; Michael G Edwards; Ryan Heiser; Joanne E Streib; Brittany Richers; Clifton F Hall; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2014-08-23       Impact factor: 10.793

2.  A discrete population of IFN λ-expressing BDCA3hi dendritic cells is present in human thymus.

Authors:  Víctor G Martínez; Noelia M Canseco; Laura Hidalgo; Jaris Valencia; Ana Entrena; Lidia M Fernández-Sevilla; Carmen Hernández-López; Rosa Sacedón; Angeles Vicente; Alberto Varas
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

3.  STAT1 Is Required for Suppression of Type 17 Immunity during Influenza and Bacterial Superinfection.

Authors:  Benjamin Lee; Radha Gopal; Michelle L Manni; Kevin J McHugh; Sivanarayana Mandalapu; Keven M Robinson; John F Alcorn
Journal:  Immunohorizons       Date:  2017-08-01

4.  Recombinant adenovirus expressing hIFN-λ1 inhibits gastric adenocarcinoma cell line SGC-7901 proliferation.

Authors:  Xuefeng Bu; Mubin Wang; Jie Zhang; Jun Liu; Lijuan Jia; Bing Liang; Yulan Yan
Journal:  Oncol Lett       Date:  2015-11-06       Impact factor: 2.967

Review 5.  The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19.

Authors:  Bruno G N Andrade; Rafael R C Cuadrat; Fernanda Raya Tonetti; Haruki Kitazawa; Julio Villena
Journal:  Biosci Microbiota Food Health       Date:  2022-03-29

6.  High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity.

Authors:  Susanne Johansson; Willem Talloen; Marianne Tuefferd; Jama Darling; Gregory Fanning; Michael W Fried; Jeroen Aerssens
Journal:  Liver Int       Date:  2015-09-06       Impact factor: 5.828

Review 7.  Important Role of the IL-32 Inflammatory Network in the Host Response against Viral Infection.

Authors:  Yaqin Zhou; Ying Zhu
Journal:  Viruses       Date:  2015-06-16       Impact factor: 5.048

8.  Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells.

Authors:  Md Aminul Islam; Leonardo Albarracin; Vyacheslav Melnikov; Bruno G N Andrade; Rafael R C Cuadrat; Haruki Kitazawa; Julio Villena
Journal:  Pathogens       Date:  2021-05-21

Review 9.  Cytokine production and signaling pathways in respiratory virus infection.

Authors:  Hirokazu Kimura; Masakazu Yoshizumi; Haruyuki Ishii; Kazunori Oishi; Akihide Ryo
Journal:  Front Microbiol       Date:  2013-09-17       Impact factor: 5.640

Review 10.  Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis.

Authors:  Ralph A Tripp
Journal:  Immune Netw       Date:  2013-10-26       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.